Lancet Oncol. 2013 Sep;14(10):1009-19. doi: 10.1016/S1470-2045(13)70301-2. Epub 2013 Jul 24.
Associations between circulating concentrations of oestrogens, progesterone, and androgens with breast cancer and related risk factors in premenopausal women are not well understood. We aimed to characterise these associations with a pooled analysis of data from seven studies.
Individual participant data for prediagnostic sex hormone and sex hormone-binding globulin (SHBG) concentrations were contributed from seven prospective studies. We restricted analyses to women who were premenopausal and younger than 50 years at blood collection, and to women with breast cancer diagnosed before age 50 years. We estimated odds ratios (ORs) with 95% CIs for breast cancer associated with hormone concentrations by conditional logistic regression in cases and controls matched for age, date of blood collection, and day of cycle, with stratification by study and further adjustment for cycle phase. We examined associations of hormones with risk factors for breast cancer in control women by comparing geometric mean hormone concentrations in categories of these risk factors, adjusted for study, age, phase of menstrual cycle, and body-mass index (BMI). All statistical tests were two-sided.
We included data for up to 767 women with breast cancer and 1699 controls in the risk analyses. Breast cancer risk was associated with a doubling in concentrations of oestradiol (OR 1·19, 95% CI 1·06-1·35), calculated free oestradiol (1·17, 1·03-1·33), oestrone (1·27, 1·05-1·54), androstenedione (1·30, 1·10-1·55), dehydroepiandrosterone sulphate (1·17, 1·04-1·32), testosterone (1·18, 1·03-1·35), and calculated free testosterone (1·08, 0·97-1·21). Breast cancer risk was not associated with luteal phase progesterone (doubling in concentration OR 1·00, 95% CI 0·92-1·09), and adjustment for other factors had little effect on any of these ORs. Cross-sectional analyses in control women showed several associations of sex hormones with breast cancer risk factors.
Circulating oestrogens and androgens are positively associated with the risk for breast cancer in premenopausal women.
循环雌激素、孕激素和雄激素浓度与绝经前妇女乳腺癌及其相关危险因素之间的关系尚不清楚。我们旨在通过对来自 7 项研究的数据进行汇总分析来描述这些关联。
从 7 项前瞻性研究中获取了绝经前且采血时年龄小于 50 岁且乳腺癌诊断年龄小于 50 岁的个体参与者数据。我们将分析仅限于激素浓度与乳腺癌相关的病例和对照者匹配年龄、采血日期和月经周期日,并按研究分层,进一步按周期阶段调整。我们通过比较这些危险因素分类中激素的几何平均浓度,调整研究、年龄、月经周期阶段和体重指数(BMI),来研究激素与对照女性乳腺癌危险因素之间的关联。所有统计检验均为双侧检验。
我们将多达 767 名乳腺癌患者和 1699 名对照者的数据纳入风险分析。乳腺癌风险与雌二醇浓度增加一倍相关(比值比 1·19,95%置信区间 1·06-1·35),计算得出的游离雌二醇(1·17,1·03-1·33)、雌酮(1·27,1·05-1·54)、雄烯二酮(1·30,1·10-1·55)、硫酸脱氢表雄酮(1·17,1·04-1·32)、睾酮(1·18,1·03-1·35)和计算得出的游离睾酮(1·08,0·97-1·21)。黄体期孕激素浓度增加一倍与乳腺癌风险无关(比值比 1·00,95%置信区间 0·92-1·09),调整其他因素对这些比值比影响不大。在对照女性中进行的横断面分析显示,几种性激素与乳腺癌危险因素之间存在关联。
循环雌激素和雄激素与绝经前妇女乳腺癌风险呈正相关。